Risk of early- and late-onset Alzheimer disease and related dementia in adults with cerebral palsy
- PMID: 34496036
- PMCID: PMC10424101
- DOI: 10.1111/dmcn.15044
Risk of early- and late-onset Alzheimer disease and related dementia in adults with cerebral palsy
Abstract
Aim: To examine the risk of Alzheimer disease and related dementia (ADRD) among adults with cerebral palsy (CP).
Method: Using administrative insurance claims data for 2007 to 2017 in the USA, we identified adults (45y or older) with a diagnosis of CP (n=5176). Adults without a diagnosis of CP were included as a typically developing comparison group (n=1 119 131). Using age, sex, ethnicity, other demographic variables, and a set of chronic morbidities, we propensity-matched individuals with and without CP (n=5038). Cox survival models were used to estimate ADRD risk within a 3-year follow up.
Results: The unadjusted incidence of ADRD was 9 and 2.4 times higher among cohorts of adults 45 to 64 years (1.8%) and 65 years and older (4.8%) with CP than the respective unmatched individuals without CP (0.2% and 2.0% among 45-64y and 65y or older respectively). Fully adjusted survival models indicated that adults with CP had a greater hazard for ADRD (among 45-64y: unmatched hazard ratio 7.48 [95% confidence interval {CI} 6.05-9.25], matched hazard ratio 4.73 [95% CI 2.72-8.29]; among 65y or older: unmatched hazard ratio 2.21 [95% CI 1.95-2.51], matched hazard ratio 1.73 [1.39-2.15]).
Interpretation: Clinical guidelines for early screening of cognitive function among individuals with CP need updating, and preventative and/or therapeutic services should be used to reduce the risk of ADRD.
© 2021 Mac Keith Press.
Conflict of interest statement
Figures
Comment in
-
Adults with cerebral palsy and Alzheimer disease: a missing link?Dev Med Child Neurol. 2022 Mar;64(3):284. doi: 10.1111/dmcn.15080. Epub 2021 Oct 10. Dev Med Child Neurol. 2022. PMID: 34632577 No abstract available.
References
-
- MacLennan AH, Thompson SC, Gecz J. Cerebral palsy: causes, pathways, and the role of genetic variants. Am J Obstet Gynecol. 2015;213(6):779–88. - PubMed
-
- Wainwright MS. Pharmacogenomics of Alzheimer’s disease and cerebral palsy: implications of the apolipoprotein E genotype. Future Medicine. 2007;2(4):353–6.
